English
Segment disclosures
Company overviewATAI LIFE SCIENCES LUXEMBOURG S.A.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 8 retained observations 6 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Reportable Segment Aggregation Before Other Operating Segment · Research And Development Services Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember;srt:ProductOrServiceAxis=atai:ResearchAndDevelopmentServicesRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1267000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2019000 | USD | 20260811 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 752000 | USD | 20260512 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3887000 | USD | 20260306 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 719000 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2072000 | USD | 20260811 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1353000 | USD | 20260512 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260306 | Open filing evidence |